94 related articles for article (PubMed ID: 28482738)
1. Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.
Østgård RD; Glerup H; Jurik AG; Kragstrup TW; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Deleuran BW
Scand J Rheumatol; 2017 Nov; 46(6):441-445. PubMed ID: 28482738
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
Song SN; Iwahashi M; Tomosugi N; Uno K; Yamana J; Yamana S; Isobe T; Ito H; Kawabata H; Yoshizaki K
Arthritis Res Ther; 2013 Oct; 15(5):R141. PubMed ID: 24286116
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity.
Heftdal LD; Stengaard-Pedersen K; Ørnbjerg LM; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B; Møller HJ; Greisen SR
Scand J Clin Lab Invest; 2017 Sep; 77(5):385-389. PubMed ID: 28598681
[TBL] [Abstract][Full Text] [Related]
4. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
[TBL] [Abstract][Full Text] [Related]
5. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.
Kim HR; Kim KW; Yoon SY; Kim SH; Lee SH
J Korean Med Sci; 2010 Mar; 25(3):348-52. PubMed ID: 20191031
[TBL] [Abstract][Full Text] [Related]
6. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Detert J; Bastian H; Listing J; Weiß A; Wassenberg S; Liebhaber A; Rockwitz K; Alten R; Krüger K; Rau R; Simon C; Gremmelsbacher E; Braun T; Marsmann B; Höhne-Zimmer V; Egerer K; Buttgereit F; Burmester GR
Ann Rheum Dis; 2013 Jun; 72(6):844-50. PubMed ID: 22739990
[TBL] [Abstract][Full Text] [Related]
7. Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis.
Isaacs JD; Harari O; Kobold U; Lee JS; Bernasconi C
Arthritis Res Ther; 2013; 15(6):R204. PubMed ID: 24295403
[TBL] [Abstract][Full Text] [Related]
8. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
9. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis.
Ammitzbøll CG; Thiel S; Jensenius JC; Ellingsen T; Hørslev-Petersen K; Hetland ML; Junker P; Krogh NS; Østergaard M; Stengaard-Pedersen K
Arthritis Rheum; 2013 Dec; 65(12):3045-50. PubMed ID: 24022747
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Hvid M; Deleuran B
Scand J Rheumatol; 2014; 43(2):101-8. PubMed ID: 24182347
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity.
Swellam M; Gabal KM; Youssef SS
IUBMB Life; 2013 Oct; 65(10):883-8. PubMed ID: 24014495
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
15. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Doyle MK; Rahman MU; Frederick B; Birbara CA; de Vries D; Toedter G; Wu X; Chen D; Ranganath VK; Westerman ME; Furst DE
Rheumatology (Oxford); 2013 Jul; 52(7):1214-9. PubMed ID: 23418046
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
Hørslev-Petersen K; Hetland ML; Ørnbjerg LM; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2016 Sep; 75(9):1645-53. PubMed ID: 26489704
[TBL] [Abstract][Full Text] [Related]
17. Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
Zipperer E; Post JG; Herkert M; Kündgen A; Fox F; Haas R; Gattermann N; Germing U
Ann Hematol; 2013 Dec; 92(12):1617-23. PubMed ID: 23842708
[TBL] [Abstract][Full Text] [Related]
18. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.
Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B
Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065
[TBL] [Abstract][Full Text] [Related]
19. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
20. Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study.
Azab SF; Akeel NE; Abdalhady MA; Elhewala AA; Ali ASA; Amin EK; Sarhan DT; Almalky MAA; Elhindawy EM; Salam MMA; Soliman AA; Abdellatif SH; Ismail SM; Elsamad NA; Hashem MIA; Aziz KA; Elazouni OMA; Arafat MS
Medicine (Baltimore); 2016 Mar; 95(9):e2921. PubMed ID: 26945394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]